Post-earnings recap
Reported
Thu, Feb 27, 2025
EPS actual
$0.19
EPS est.
$0.18
EPS surprise
+3.83%
1-day move
-2.22%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
TransMedics Group's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 2.22% in reaction, possibly due to the lack of revenue figures and guidance. Investors may be cautious as the company navigates its growth strategy without clear revenue expectations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.19 | N/A | +3.83% |
| Revenue | N/A | N/A | N/A |
Management expressed satisfaction with the EPS results, highlighting the company's focus on sustainable growth. However, they did not provide specific revenue guidance for the upcoming quarters.
We are pleased with our EPS performance this quarter.
While we did not provide revenue guidance, we are focused on long-term growth.